Concert Pharma (CNCE) –
-
Form 15-12G CONCERT PHARMACEUTICALS,
-
Form EFFECT CONCERT PHARMACEUTICALS,
-
Form EFFECT CONCERT PHARMACEUTICALS,
-
Form EFFECT CONCERT PHARMACEUTICALS,
-
Form EFFECT CONCERT PHARMACEUTICALS,
-
Form 25-NSE CONCERT PHARMACEUTICALS, Filed by: Nasdaq Stock Market LLC
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: van Heek Christi
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: Tung Roger D
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: Stuart Nancy
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: Munsie Jeffrey A
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: JAEGER WILFRED E
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: HUTT PETER BARTON
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: Hoeiland Jesper
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: Cassella James V
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: Becker Marc A.
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: Auchincloss Thomas G
-
Form 4 CONCERT PHARMACEUTICALS, For: Mar 06 Filed by: ALDRICH RICHARD
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form S-8 POS CONCERT PHARMACEUTICALS,
-
Form POS AM CONCERT PHARMACEUTICALS,
-
Form POS AM CONCERT PHARMACEUTICALS,
-
Form POS AM CONCERT PHARMACEUTICALS,
-
Form POS AM CONCERT PHARMACEUTICALS,
-
Form 8-K CONCERT PHARMACEUTICALS, For: Mar 03
-
Form SC 14D9/A CONCERT PHARMACEUTICALS, Filed by: CONCERT PHARMACEUTICALS, INC.
-
Form SC TO-T/A CONCERT PHARMACEUTICALS, Filed by: SUN PHARMACEUTICAL INDUSTRIES LTD
-
Form SC TO-T/A CONCERT PHARMACEUTICALS, Filed by: SUN PHARMACEUTICAL INDUSTRIES LTD
-
Form SC 14D9/A CONCERT PHARMACEUTICALS, Filed by: CONCERT PHARMACEUTICALS, INC.
-
Form 4 CONCERT PHARMACEUTICALS, For: Feb 15 Filed by: Stuart Nancy
-
Form 4 CONCERT PHARMACEUTICALS, For: Feb 15 Filed by: Munsie Jeffrey A
-
Form 4 CONCERT PHARMACEUTICALS, For: Feb 15 Filed by: Cassella James V
-
Form 4 CONCERT PHARMACEUTICALS, For: Feb 15 Filed by: Becker Marc A.
-
Concert Pharma (CNCE) Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA
-
Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata
-
Form SC 13G/A CONCERT PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A CONCERT PHARMACEUTICALS, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SC 13G/A CONCERT PHARMACEUTICALS, Filed by: BIOTECHNOLOGY VALUE FUND L P
-
Form SC 13G CONCERT PHARMACEUTICALS, Filed by: Kynam Capital Management, LP
-
Form SC 13G CONCERT PHARMACEUTICALS, Filed by: Kynam Capital Management, LP
-
Form SC 14D9 CONCERT PHARMACEUTICALS, Filed by: CONCERT PHARMACEUTICALS, INC.
-
Form SC TO-T CONCERT PHARMACEUTICALS, Filed by: SUN PHARMACEUTICAL INDUSTRIES LTD
-
Form SC TO-C CONCERT PHARMACEUTICALS, Filed by: SUN PHARMACEUTICAL INDUSTRIES LTD
-
Form SC TO-C CONCERT PHARMACEUTICALS, Filed by: SUN PHARMACEUTICAL INDUSTRIES LTD
Back to CNCE Stock Lookup